标题
AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review
作者
关键词
-
出版物
Cancers
Volume 13, Issue 10, Pages 2287
出版商
MDPI AG
发表日期
2021-05-11
DOI
10.3390/cancers13102287
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis
- (2021) Nico Hinz et al. Cells
- Transcriptome Analysis Reveals Key Genes and Pathways Associated with Metastasis in Breast Cancer
- (2020) Wei Li et al. OncoTargets and Therapy
- Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)
- (2020) Aaron C. Tan Thoracic Cancer
- Effect of GNAQ alteration on RANKL-induced osteoclastogenesis in human non-small-cell lung cancer
- (2020) Ji-Yoon Choi et al. Bone & Joint Research
- A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (CAPItello290).
- (2020) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells
- (2020) Michela Deiana et al. Cells
- AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway
- (2020) Guang-Fu Hu et al. Annals of Translational Medicine
- Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow
- (2020) Johanna M. Buschhaus et al. ONCOGENE
- Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c‐Fos/NFATc1 signaling pathway
- (2020) Wenli Jiang et al. Cancer Medicine
- High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
- (2020) Daniel J. Smit et al. Cells
- Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells
- (2020) Masayoshi Yamaguchi et al. Translational Oncology
- Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition
- (2019) Min A. Seol et al. Scientific Reports
- A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway
- (2019) Chia-Ling HSIEH et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
- (2019) Jingbo Sun et al. Cancer Cell International
- Distinct functions of AKT isoforms in breast cancer: a comprehensive review
- (2019) Nico Hinz et al. Cell Communication and Signaling
- The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment
- (2019) Mitsuru Futakuchi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients
- (2019) Claire L. Ihle et al. Journal for ImmunoTherapy of Cancer
- Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial
- (2019) Peter Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteocyte-Driven Downregulation of Snail Restrains Effects of Drd2 Inhibitors on Mammary Tumor Cells
- (2018) Shengzhi Liu et al. CANCER RESEARCH
- M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis
- (2018) Richa Shrivastava et al. CYTOKINE
- Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling
- (2018) Yubo Tang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Recombinant MDA-7/IL-24 suppresses prostate cancer bone metastasis through down regulation of the Akt/Mcl-1 pathway
- (2018) Anjan K Pradhan et al. MOLECULAR CANCER THERAPEUTICS
- Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway
- (2018) Song Xu et al. Molecular Medicine Reports
- SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2
- (2018) Meng Xu et al. ONCOLOGY REPORTS
- Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling
- (2018) Andrea Mancini et al. TUMOR BIOLOGY
- Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells
- (2018) Qiang Wang et al. Cell Death & Disease
- Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma
- (2018) Sebastian Frees et al. Oncotarget
- Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway
- (2018) Junlin Shi et al. Oncotarget
- Bone metastasis pattern in initial metastatic breast cancer: a population-based study
- (2018) Zhenchong Xiong et al. Cancer Management and Research
- The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
- (2018) Michael Mc Kenna et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- In Vitro and In Vivo Antimetastatic Effects of ZSTK474 on Prostate Cancer DU145 Cells
- (2018) Jie Liu et al. CURRENT CANCER DRUG TARGETS
- Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network
- (2018) Xinhua Chen et al. MEDICINE
- Somatic mutations, clinicopathologic characteristics, and survival in patients with untreated breast cancer with bone-only and non-bone sites of first metastasis
- (2018) Miho Kono et al. Journal of Cancer
- Akt1 inhibition promotes breast cancer metastasis through EGFR-mediated β-catenin nuclear accumulation
- (2018) Wei Li et al. Cell Communication and Signaling
- Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
- (2018) Johann S. de Bono et al. CLINICAL CANCER RESEARCH
- Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis
- (2018) Guixin Yuan et al. CANCER LETTERS
- Metastatic bone disease: Pathogenesis and therapeutic options
- (2018) Stella D'Oronzo et al. Journal of Bone Oncology
- Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
- (2017) Andrew S. Gdowski et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Sung-Bae Kim et al. LANCET ONCOLOGY
- MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2
- (2017) Melissa Colden et al. Cell Death & Disease
- FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis
- (2017) Feng Xie et al. Nature Communications
- A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
- (2016) C. X. Ma et al. CLINICAL CANCER RESEARCH
- Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro
- (2016) Masayoshi Yamaguchi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer
- (2016) Kenta Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines
- (2016) M. Fragni et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis
- (2016) M Tandon et al. ONCOGENE
- Bone Morphogenetic Proteins
- (2016) Takenobu Katagiri et al. Cold Spring Harbor Perspectives in Biology
- Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?
- (2016) Daniele Fanale et al. Oncotarget
- Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts
- (2016) Ming-Xuan Feng et al. Scientific Reports
- The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
- (2015) Hai Wang et al. CANCER CELL
- Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone
- (2015) Wenjing Zhu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs
- (2015) Shuai Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Pattern of metastasis and outcome in patients with breast cancer
- (2015) L. Gerratana et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis
- (2015) Antonia Sophocleous et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- Bone Metastasis in Renal Cell Carcinoma is Preprogrammed in the Primary Tumor and Caused by AKT and Integrin α5 Signaling
- (2015) Tobias Haber et al. JOURNAL OF UROLOGY
- RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
- (2015) Karine A. Cohen-Solal et al. Molecular Cancer
- Syringetin suppresses osteoclastogenesis mediated by osteoblasts in human lung adenocarcinoma
- (2015) YING-MING TSAI et al. ONCOLOGY REPORTS
- Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models
- (2015) Yu-Hsiang Hsu et al. PLoS One
- Suppression of Early Hematogenous Dissemination of Human Breast Cancer Cells to Bone Marrow by Retinoic Acid-Induced 2
- (2015) S. Werner et al. Cancer Discovery
- TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model
- (2015) Hendrik Fritsche et al. Oncotarget
- Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
- (2015) Florian Ewald et al. Journal of Cancer
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer
- (2015) Leigh Ellis et al. Oncotarget
- An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo
- (2015) Shafaat A. Rabbani et al. NEOPLASIA
- Medical Treatment of Breast Cancer Bone Metastasis: From Bisphosphonates to Targeted Drugs
- (2014) Bulent Erdogan et al. Asian Pacific Journal of Cancer Prevention
- Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
- (2014) Claudia Fumarola et al. BIOCHEMICAL PHARMACOLOGY
- miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer
- (2014) S. Josson et al. CLINICAL CANCER RESEARCH
- Bone-derived soluble factors and laminin-511 cooperate to promote migration, invasion and survival of bone-metastatic breast tumor cells
- (2014) Delphine Denoyer et al. GROWTH FACTORS
- Bone-induced c-kit expression in prostate cancer: A driver of intraosseous tumor growth
- (2014) Leandro E. Mainetti et al. INTERNATIONAL JOURNAL OF CANCER
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- (2014) CHIA-JUNG HSIEH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- CCL5 secreted from bone marrow stromal cells stimulates the migration and invasion of Huh7 hepatocellular carcinoma cells via the PI3K-Akt pathway
- (2014) HUILI BAI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High calcium concentration in bones promotes bone metastasis in renal cell carcinomas expressing calcium-sensing receptor
- (2014) Elke Joeckel et al. Molecular Cancer
- Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture
- (2014) Shabnam Ziaee et al. Molecular Cancer
- Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis
- (2014) J-K Jin et al. ONCOGENE
- BMP9 Inhibits Proliferation and Metastasis of HER2-Positive SK-BR-3 Breast Cancer Cells through ERK1/2 and PI3K/AKT Pathways
- (2014) Wei Ren et al. PLoS One
- Akt Activation is Required for TGF-β1-Induced Osteoblast Differentiation of MC3T3-E1 Pre-Osteoblasts
- (2014) Eiichi Suzuki et al. PLoS One
- Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer
- (2014) HENG ZENG et al. Oncology Letters
- BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells
- (2014) Shaoheng Wan et al. CELLULAR ONCOLOGY
- Vitronectin- v 3 Integrin Engagement Directs Hypoxia-Resistant mTOR Activity and Sustained Protein Synthesis Linked to Invasion by Breast Cancer Cells
- (2013) C. Pola et al. CANCER RESEARCH
- CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway
- (2013) Po-Chun Chen et al. CARCINOGENESIS
- Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
- (2013) Xiang H.-F. Zhang et al. CELL
- Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
- (2013) Florian Ewald et al. INTERNATIONAL JOURNAL OF CANCER
- Bone marrow mesenchymal stem cells increase motility of prostate cancer cellsviaproduction of stromal cell-derived factor-1α
- (2013) Barbara Mognetti et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
- (2013) M Conley-LaComb et al. Molecular Cancer
- PLZF Mediates the PTEN/AKT/FOXO3a Signaling in Suppression of Prostate Tumorigenesis
- (2013) JingPing Cao et al. PLoS One
- Treatment patterns and characteristics of European patients with castration-resistant prostate cancer
- (2013) Cora N Sternberg et al. BMC Urology
- The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro– evaluation towards understanding breast cancer cell bone metastasis
- (2012) William Weidong Du et al. BMC CANCER
- Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
- (2012) T Tawadros et al. BRITISH JOURNAL OF CANCER
- Bone-Derived IGF Mediates Crosstalk between Bone and Breast Cancer Cells in Bony Metastases
- (2012) Toru Hiraga et al. CANCER RESEARCH
- CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis
- (2012) J.-H. Lee et al. CANCER RESEARCH
- CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells
- (2012) P.-C. Chen et al. CARCINOGENESIS
- PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription
- (2012) Kaijie Wu et al. CELLULAR SIGNALLING
- Incidence and Patterns of Distant Metastases for Patients With Early-Stage Breast Cancer After Breast Conservation Treatment
- (2012) Abigail T. Berman et al. Clinical Breast Cancer
- Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis
- (2012) John G Logan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis
- (2012) Yiwei Li et al. PLoS One
- Pathobiological Implications of the Expression of EGFR, pAkt, NF-κB and MIC-1 in Prostate Cancer Stem Cells and Their Progenies
- (2012) Murielle Mimeault et al. PLoS One
- In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors
- (2012) Reynald M. Lescarbeau et al. PLoS One
- Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways
- (2012) Farshid Dayyani et al. PLoS One
- Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer
- (2011) M. Gallo et al. ANNALS OF ONCOLOGY
- FOXO1 Inhibits Runx2 Transcriptional Activity and Prostate Cancer Cell Migration and Invasion
- (2011) H. Zhang et al. CANCER RESEARCH
- Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1
- (2011) Ling Chen et al. CARCINOGENESIS
- A Novel HSP90 Inhibitor Delays Castrate-Resistant Prostate Cancer without Altering Serum PSA Levels and Inhibits Osteoclastogenesis
- (2011) F. Lamoureux et al. CLINICAL CANCER RESEARCH
- Metastatic function of BMP-2 in gastric cancer cells: The role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression
- (2011) Myoung Hee Kang et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
- (2011) Hiroshi Urakawa et al. INTERNATIONAL JOURNAL OF CANCER
- Akt Induces Osteoclast Differentiation through Regulating the GSK3 /NFATc1 Signaling Cascade
- (2011) J. B. Moon et al. JOURNAL OF IMMUNOLOGY
- Lung Tumor-Associated Dendritic Cell-Derived Amphiregulin Increased Cancer Progression
- (2011) Y.-L. Hsu et al. JOURNAL OF IMMUNOLOGY
- CCN1, a Candidate Target for Zoledronic Acid Treatment in Breast Cancer
- (2011) I. Espinoza et al. MOLECULAR CANCER THERAPEUTICS
- Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption
- (2011) Young Sun Hwang et al. ORAL ONCOLOGY
- Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
- (2011) Swati Biswas et al. PLoS One
- Phospholipase D signaling pathway is involved in lung cancer-derived IL-8 increased osteoclastogenesis
- (2010) Ya-Ling Hsu et al. CARCINOGENESIS
- TGF-β Pathway as a Therapeutic Target in Bone Metastases
- (2010) Patricia Juarez et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
- (2010) J. Zhang et al. JNCI-Journal of the National Cancer Institute
- SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis
- (2010) S. A. Rabbani et al. MOLECULAR CANCER THERAPEUTICS
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway
- (2009) Myoung Hee Kang et al. EXPERIMENTAL CELL RESEARCH
- Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesisviathe HIF-1α/VEGF signaling pathways in human breast cancer cells
- (2009) Xudong Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Prevention and Management of Bone Metastases in Lung Cancer: A Review
- (2009) Hamed Al Husaini et al. Journal of Thoracic Oncology
- EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling
- (2009) Alyse M. DeHaan et al. PROSTATE
- Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/FAK/Akt and NF-κB-dependent pathway
- (2008) Yi-Chin Fong et al. LUNG CANCER
- PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
- (2008) Lana Bozulic et al. MOLECULAR CELL
- Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients
- (2008) Ilaria Roato et al. PLoS One
- Inhibition of Hsp90 activates osteoclast c-Src signaling and promotes growth of prostate carcinoma cells in bone
- (2008) A. Yano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins
- (2008) Tzu-Hsiu Lai et al. PROSTATE
- PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-κB in metastatic prostate cancer cells
- (2008) Tisheeka R. Graham et al. PROSTATE
- Osteoblasts-derived TGF-β1 enhance motility and integrin upregulation through Akt, ERK, and NF-κB-dependent pathway in human breast cancer cells
- (2007) Ying-Ying Wei et al. MOLECULAR CARCINOGENESIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started